The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials
ConclusionFluoxetine improved FMMS and reduced anxiety and depression. More well-designed and large sample-size RCTs are required to further analyze the efficacy of fluoxetine in post-stroke recovery.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Anxiety | Clinical Trials | Databases & Libraries | Depression | Drugs & Pharmacology | Fluoxetine | Gastroenterology | Infectious Diseases | Insomnia | MRSA | Prozac | Stroke | Study | Superbugs